An upcoming event will celebrate the achievements of women in cannabis – and highlight where the sector falls short for them.
A panel of patients, activists, mothers, clinicians and scientists from across the globe will celebrate the significant role women have played in changing attitudes – and policies – around cannabis.
The event, being held on Monday 28 March, to mark the end of Women’s History Month, also aims to explore some of the current issues facing women in the sector and will see some frank discussions around where the cannabis industry could do better.
A recent study from the US found that despite 37 per cent of executive positions in the cannabis, CBD and hemp industry being held by women in 2017, that number has now dropped significantly to just 22 per cent.
Only 11 per cent of respondents agreed that the US cannabis industry is equitable, with problems such as sexism, harassment, bullying, lack of support, benefits, opportunity and respect, difficulty obtaining funding and resources, low pay, shame and stigma are all cited as barriers.
Almost three-quarters of women felt the need to work harder than their male counterparts to gain respect, 67 per cent said they feel they are taken less seriously because they are women and only 25 per cent are paid the same as their male colleagues.
But despite some discouraging data, women have played a significant role in campaigning and advocating for policy changes that have made the cannabis industry possible.
The event, moderated by British cannabis author and podcaster, Mary Biles, will see panelists share their own experiences of being women in the cannabis industry, as well as the challenges of navigating their countries’ political processes and the personal sacrifices made by parents and patient activists.
Panelists include Irish medical cannabis campaigner Vera Twomey and Jacqueline Poitras, founder of ‘MAMAKA- Mothers for Cannabis’, who played a leading role in cannabis policy changes in Greece.
They will be joined by Carola Perez, director of the Spanish Observatory of Medicinal Cannabis (OECM), Polita Pepper, co-founder and director of the Civil Association CANNATIVA A.C in Mexico, Italy’s Dr Viola Brugnatelli, cannabis scientist and founder of Cannabiscientia, and representing the UK, registered nurse and clinical trial manager for LVL Health, Sophie Hayes.
Carola Perez commented: “It’s amazing to be part of this event because we have all known each other for many years now. We have been fighting together, crying together, working together, supporting each other and being part of this panel is a dream come true.
“I think we are in a moment in the history of cannabis where some things are not really fair for women but we have the opportunity now to raise our voices, share our experiences and let people know that women in cannabis know how to work together to support each other and to have a different perspective of this amazing plant.”
As well as addressing the barriers to entry, gender inequalities and misogyny they have experienced, the panel will also discuss what unique qualities women bring to the industry and how we can encourage more to join.
Sophie Hayes added: “I am very excited to be able to speak as part of this incredible panel of women to highlight the importance of women’s voices in the field of medical cannabis.
“It remains a field predominantly occupied by men and I hope through our conversation we will encourage more women into not only the medical cannabis field but into medicine and research.”
Women in Cannabis – A Global Perspective, takes place on Monday 28 March at 7pm, register for free here.
CBD by British Cannabis™ launches in Selfridges
The brands collection of 100 per cent cannabis supplements will be available in one of the UK’s most famous premium-retailers.
British Cannabis™ has launched its collection of 100 per cent cannabis supplements and cosmetics in one of the UK’s most famous premium-retailers.
From today (Monday 4 July) the full range of CBD by British Cannabis™ products debuts in Selfridges London at the new Feel Good Bar, located in the Beauty Hall, as well as online.
Since launching seven years ago, British Cannabis™ (listed as CBD Health Foods Ltd) has experienced exceptional demand for its high quality and great tasting CBD products.
Today, the company is to launch their premium, flagship range in Selfridges.
The CBD by British Cannabis™ collection will be showcased in the Beauty Hall at Selfridges London, a place to discover products that spark innovative wellbeing practices and thought-provoking ideas and home to world-leading brands.
CBD by British Cannabis™ products have won multiple awards in recent years, including the Highly Commended 2021, P3 MVP Award for 1000mg CBD Cannabis Oils, ICP magazine’s 2022 CBD Product of The Year, and Your Healthy Living magazine’s 2022 Silver Award for Best CBD Products (for CBD by British Cannabis™ Dermal Patches 500mg).
All of the food supplement products in the CBD by British Cannabis™ collection are included on the Food Standards Agency’s public list of products that are legal for sale on the UK market via the successful submission of British Cannabis’™ Novel Foods applications.
A recent update by the governments Food Standards Agency saw British Cannabis™ ranked as the UK’s largest CBD manufacturer by number of publicly listed CBD products manufactured.
More than just CBD – The British Cannabis™ Story
CBD by British Cannabis™ is not ‘just CBD’; these 100 per cent cannabis products contain hundreds of other beneficial cannabis compounds, terpenes, flavonoids, phenols and more.
All of these natural elements and yet still being compliant with regulations and legal for sale within the UK. Each product is rigorously tested for accuracy, purity, and THC-free status for consumer peace of mind.
Every product contains the knowledge and expertise that has been amassed over the last seven years of British Cannabis™ existence, evidenced in the growing, extraction, research, development, and manufacturing that saw this British start-up grow to be the leading authority in consumer cannabis products within the UK.
British Cannabis™ CEO, Thomas Whettem, celebrated the news, commenting: “This is yet another great milestone in the British Cannabis™ story. It is a testament to the levels of excellence we demand within our supply chain and products, that we are now stocked at an iconic, prestige retailer in Selfridges.
“We set out to create ‘the champagne of CBD oils’, with more beneficial cannabis phytochemicals than any other CBD products compliant and legal for sale today. Our premium, THC-free products are both UK-born and UK-manufactured, thus debuting in Selfridges London seems very appropriate.”
British Cannabis™ launched a television campaign in March 2022 for its premium flagship range, CBD by British Cannabis™, as part of a half a million pound investment in awareness building and consumer recruitment 2022/23.
Set in the style of a classic health and beauty advert, the creative aimed to break down barriers to legal cannabis-derived products, gaining broadcaster approval to make more industry-specific references than any campaign to date.
Shown across dozens of premium channels on the SKY and Channel 5 networks, this marked the first time that the SKY network had opened its doors to CBD advertisers on their linear stations since 2019.
British Cannabis™ Managing Director, David Ralson, said: “As proud as we are of our tested, trusted, super-premium CBD supplements and cosmetics, we are equally proud to now be bringing them to the world-class shopping experience at Selfridges, as part of our distribution expansion plans.
“For over a century, Selfridges have brought premium health and beauty products to the forefront in exciting ways – and especially in their new Feel Good Bar. As one of the UK’s original British-made CBD ranges, with a heritage in this young industry of nearly seven years, the match of Selfridges and CBD by British Cannabis™ seems a perfect fit.
“I hope that Selfridges shoppers grow to love and trust our CBD range as much as our existing loyal customer base, who over the years have given us over 1,500 5-star reviews on Trustpilot.”
BRITISH CANNABIS™ can be reached on +44 (0) 203 965 2420 or via email at [email protected]
Find us on LinkedIn – Search ‘BRITISH CANNABIS’ or search ‘@BritishCanna’ for Facebook and Twitter.
New fully digital cannabis dispensary launches in UK
It aims to streamline the process through which cannabis patients can access their medicine.
A new fully digital medical cannabis pharmacy aims to improve the dispensing experience for UK patients.
A new digital dispensing solution has launched in the UK, with the aim of streamlining the process through which cannabis patients can access their medicine.
Through the new system, patients are able to schedule delivery to their home or office, with a 120-minute delivery service in London and Birmingham and next-day delivery across the UK.
Akanda subsidiary, CanMart, has partnered with digital pharmacy infrastructure Phlo Connect and Cellen Life Sciences to bring the project to life.
The process will be increasingly seamless for patients in the near future as Phlo Connect, Cellen and CanMart build additional digital interconnections, Akanda said.
Tej Virk, CEO of Akanda, said: “Akanda is committed to expanding access to high-quality products for anyone in need, and that is qualified in the United Kingdom, a growing market for medical cannabis.
“Phlo Connect and Cellen are the ideal partners to make this happen, combining the UK’s first fully digital pharmacy with a digital dispensing model that is easy to use, secure, and real-time.
“In the nascent UK medical cannabis market, patients currently suffer from excess friction as the prescription process, and last-mile delivery is disjointed.
“We firmly believe that our solution is the best way to satisfy patients and get our 1P and 3P-supplied medical cannabis in their hands quickly and conveniently, which will greatly improve the patient experience.”
The partnership with Phlo Connect builds on CanMart’s existing partnership with Cellen, a health tech company that provides treatment to chronic pain patients through Leva Clinic, as well as through partners including the NHS, and Boots UK.
The Leva Clinic, which is licensed and regulated by the Care Quality Commission, is one of the first fully digital pain clinics in the UK.
Cellen is also a medical cannabis supplier to Project Twenty21, the large-scale medical cannabis observational study monitored by Drug Science that aims to improve access to medical cannabis.
Adam Hunter, CCO of Phlo Connect commented: “We believe partnering with CanMart and Cellen will be a game-changer for medicinal cannabis patients here in the UK.
“By integrating with both CanMart and Cellen via our API-driven pharmacy platform, we believe that this partnership is the first truly end-to-end digital experience for medicinal cannabis patients in the UK.”
He added: “Our patients require access to new high-quality products without the friction and hassle of traditional dispensing services. This partnership is another example of our continuing efforts to build on our national, established relationships with the wider pharmaceutical community in innovative ways.
“We believe that CanMart’s access to high quality products as well as Phlo Connect’s extensive capabilities in dispensing will go a long way to helping our service to our patients.”
CiiTECH celebrates five years with five days of CBD offers
CiiTECH’s five-year birthday is a pivotal moment, the company said.
Cannabis healthcare company CiiTECH celebrates its fifth birthday and reflects on a turbulent half-decade for the CBD industry.
CiiTECH’s five-year birthday is a pivotal moment, the company said. After what has been one of the most turbulent times for the industry, the firm has achieved six months of stability. With new crypto projects on the horizon and new markets on the cards, the company is gearing up for a period of growth.
CBD is a tough industry to be in right now but that has never stopped CiiTECH CEO and founder, Clifton Flack, from driving the business through regulatory issues and the challenges of an increasingly saturated market.
“When we started the business in 2017 the market was approaching the peak of interest and excitement. Since then, alongside the hundreds of brands that have been born to compete with us, we’ve also faced monumental regulatory pressures and flip-flopping,” Flack said.
“We’re still here though, independent and with a bright future ahead as the coming year ahead brings settled regulations.”
After a stormy start to the year, the FSA delivered on their promise to roll out a framework by which products can be set on a supervised pathway to novel food authorisation. The market is now more difficult than ever to penetrate for new and emerging brands, however it gives established UK CBD companies like CiiTECH an advantage over international companies attempting to penetrate the UK market.
“In parallel, the industry and our peers have had a two year pandemic, Brexit supply chain disruptions and now a cost of living crisis set to put all previous volatilities to shame,” Flack added.
“Now more than ever, cannabis healthcare companies need to take our time, avoid the panic and focus on delivering quality products behind trusted brands that are built for the long term.”
Recently, CiiTECH investigated a stock market listing on the London Stock Exchange but the IPO did not come to fruition.
“As the CEO, I had to make an impossible decision,” Flack said.
“Amongst other things, the timing was just not right. Consumer sentiment and demands are volatile and we found the essence of our company getting lost in bureaucracy at a time when it should have been front of mind.
Yesterday, CiiTECH launched five promotions over five days to celebrate the anniversary of the company.
“As a revenue-driven business, CiiTECH would not be in the position it is today without its army of loyal Provacan customers, so we’re giving back to them the best way we know-how.
“With five days’ worth of promos and freebies to mark five years of success. Our Friday promo emails have become somewhat legendary among our customers but we have never done anything like this before.”
- CBD by British Cannabis™ launches in Selfridges
- Patient groups are key to a thriving cannabis industry – so support us, say campaigners
- 10 key patient takeaways from Cannabis Europa
- New fully digital cannabis dispensary launches in UK
- CiiTECH celebrates five years with five days of CBD offers
- Researchers are using firefly genes to understand cannabis biology
- News2 years ago
Community extends support to cannabis icon Rick Simpson
- News2 years ago
Cancer survivor claims cannabis oil helped her beat brain tumour
- Case Studies2 years ago
CBD oil and fibromyalgia – a case study
- News2 years ago
NHS lines up cannabis medicine manufacturing
- News2 years ago
Living with chronic fatigue – my CBD story
- News1 year ago
UK grants second licence to grow high-THC medical cannabis
- Insight2 years ago
I’ve gone from a wheelchair to walking thanks to cannabis
- Feature2 years ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt